All Articles: News
Vrishali Salian, a graduate student in the College of Pharmacy’s Department of Pharmaceutics, is the winner of the 2021 University of Minnesota Graduate School’s (Virtual) 3-Minute ThesisⓇ (3MT) competition.
The University of Minnesota College of Pharmacy is proud to host the nation's first Project ECHO (Extension for Community Healthcare Outcomes) program focused on pharmacogenomics-informed clinical care. Pharmacogenomics (PGx) ECHO launched in October 2021 and focuses on improving a health professional’s confidence in utilizing PGx in patient care by providing case-based education and consultation through telementoring.
The University of Minnesota Center for Orphan Drug Research and the Department of Theater Arts and Dance are collaborating to develop a new production focused on bringing attention to those diagnosed with a rare disease.
University of Minnesota (UMN) College of Pharmacy (Twin Cities) and UMN Medical School (Duluth) faculty, students, and staff teamed together at the 2021 Minnesota State Fair to ask Minnesotans about their beliefs and perceptions regarding the innovative science of pharmacogenomics (PGx).
Voting is now open for this year’s Collegiate Inventors CompetitionⓇ hosted by the National Inventors Hall of FameⓇ which features the invention of first-year student, Katelyn France.
Dr. Raj Suryanarayanan (Sury), professor and William and Mildred Peters Endowed Chair at the College of Pharmacy and Distinguished University Teaching Professor at the University of Minnesota, has been awarded the 2021 Michael J. Pikal NIPTE Distinguished Scholar Award in Pharmaceutical Processing.
Dr. Brian Isetts joins partners in MidAtlantic, Midwest and Hawaii regions.
Brittany Stampohar (Hartmann) has accepted the position of chief of operations for the University of Minnesota College of Pharmacy, Duluth campus, effective July 12, 2021. This is a new position for the College of Pharmacy and one that will add to the strong leadership team within the college.
Thanks to a research collaboration between the Institute for Therapeutics Discovery & Development and Mayo Clinic, a drug that shows promise for glaucoma patients has moved to Phase I/II clinical trials.
Broadway Family Medicine Clinic was named a 2020 MPhysicians Clinical Training Site of Excellence through OACA.